NYGC: Mary-Claire King
Mary-Claire King has joined the New York Genome Center faculty on a consulting basis as a senior associate core member. She is the American Cancer Society Professor in the Department of Genome Sciences and Medicine at the University of Washington in Seattle. At the NYGC, she will work closely with Thomas Lehner, the center's recently appointed scientific director of neuropsychiatric disease, and act as a senior adviser to both Lehner and Tom Maniatis, the center's CEO.
Twist Bioscience: Patrick Finn
Patrick Finn has been promoted from senior VP of commercial operations to chief operating officer of Twist Bioscience, a new position at the company. Prior to joining Twist in 2015, Finn was VP of sales at Enzymatics, and before that, he held various positions at Agilent Technologies, Beckman Coulter, Invitrogen, and GE Healthcare/Amersham International. He holds a PhD in nucleic acid chemistry from the University of Southampton in England and a BSc in chemistry from Heriot-Watt University in Scotland.
Sophia Genetics: Milton Silva-Craig
Sophia Genetics has named Milton Silva-Craig to its board of directors. Silva-Craig currently serves as CEO of Q-Centrix, a maker of healthcare data management technology. He previously headed the healthcare business unit of TransUnion and was president and CEO of Emageon, a health imaging software company that he helped lead through an initial public offering before that firm was sold to revenue-cycle management technology vendor Health Systems Solutions.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.